This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Thrombolysis  • Neurology  • Cerebrovascular Disease  • Stroke  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Cardiovascular Intervention  • Alert me on articles by topic  Social Bookmarking   What's this?

Optimizing the Response to a Common Threat

James F. Toole, MD; David C. Sane, MD; Kerstin Bettermann, MD, PhD

JAMA. 2004;292:1885-1887.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of JAMA, the articles by Tran and Anand¹ and Spagnoli and colleagues² contribute useful information about prevention of ischemic stroke. Tran and Anand rightly consider that atherosclerosis is a patchy disease for which platelet anti-aggregants, in addition to reduction of modifiable risk factors, are recommended and have chosen transient ischemic attack (TIA) and cerebral infarction as the indices for the successful intervention. The authors consider aspirin alone and in combination with clopidogrel, ticlopidine, and dipyridamole and conclude that clopidogrel alone or with aspirin is the most efficacious method for primary and secondary prevention of TIA and recurrent ischemic stroke. However, they concentrate only on antiplatelet therapy and do not specifically address the important effects of diet, lipids, exercise, smoking, and other modifiable risk factors.

As reviewed by Tran and Anand, aspirin and clopidogrel (or combined . . . [Full Text of this Article]

Author Affiliations: Departments of Neurology (Drs Toole and Bettermann) and Cardiology (Dr Sane), Wake Forest University School of Medicine, Winston-Salem, NC.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Extracranial Thrombotically Active Carotid Plaque as a Risk Factor for Ischemic Stroke
, , , , , , , , , and
JAMA. ;292():1845-1852.
FULL TEXT  

Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease
and
JAMA. ;292():1867-1874.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Emerging impact of CTA/perfusion CT on acute stroke thrombolysis in a community hospital
Brant-Zawadzki et al.
Journal of NeuroInterventional Surgery 2009;0:jnis.2009.000091v1-jnis.2009.000091.
ABSTRACT | FULL TEXT  

Surgery for carotid artery stenosis: Author's reply
Toole
BMJ 2004;329:1344-1345.
FULL TEXT